Paget Disease of the Nipple

---

Summary

Paget Disease of the Nipple is a rare form of breast cancer that is characterized by malignant cells in the nipple and areola. It is classified histologically as a ductal carcinoma, indicating that it originates in the milk ducts of the breast.

Symptoms

The symptoms of Paget Disease of the Nipple often resemble eczema and can include:

• Itching or tingling in the nipple or areola
• Redness or flaky skin on the nipple
• Yellowish or bloody discharge from the nipple
• A flattened or inverted nipple
• A lump in the breast (in about 50% of cases)

Standard Treatments

1. Surgery:

   • Mastectomy: Removal of the entire breast is a common treatment, especially if invasive cancer is present.
   • Breast-Conserving Surgery: Also known as lumpectomy, this involves removing the cancerous tissue while preserving as much of the breast as possible.

2. Radiation Therapy: Often used after breast-conserving surgery to eliminate any remaining cancer cells.

3. Chemotherapy: This may be recommended if the cancer is invasive, particularly if it has spread to lymph nodes or other parts of the body.

4. Hormone Therapy: Used if the cancer cells have hormone receptors. Common drugs include tamoxifen or aromatase inhibitors.

5. Targeted Therapy: Medications like trastuzumab (Herceptin) may be used for HER2-positive cancers.

Dates and Modernity

• The surgical management of Paget Disease has been consistently refined over the decades, with breast-conserving surgeries becoming more prevalent since the 1980s.
• Radiation therapy has been a standard treatment since the mid-20th century, with advancements in techniques reducing side effects and improving efficacy.
• Chemotherapy and hormone therapies have evolved significantly since the 1990s, with newer drugs continuing to emerge.
• Targeted therapies have been a part of treatment regimens since the early 2000s, with ongoing research expanding their use.

Experimental Treatments

Research is ongoing to find more effective treatments for Paget Disease of the Nipple. Some experimental approaches include:

• Immunotherapy: This involves stimulating the patient's immune system to attack cancer cells. Clinical trials are exploring the efficacy of immune checkpoint inhibitors.
• Gene Therapy: Experimental studies are investigating the potential of modifying genes to treat breast cancer.
• Monoclonal Antibodies: Newer antibodies are being tested in clinical trials for their ability to target specific proteins on cancer cells.

Side Effects of Treatments

Surgery

• Pain and scarring
• Changes in breast shape or appearance
• Risk of infection

Radiation Therapy

• Skin irritation or burns
• Fatigue
• Swelling of the breast

Chemotherapy

• Nausea and vomiting
• Hair loss
• Increased risk of infection

Hormone Therapy

• Hot flashes
• Risk of blood clots
• Bone thinning

Targeted Therapy

• Heart problems (specifically with trastuzumab)
• Diarrhea
• Liver problems

Experimental Treatments

• Immunotherapy and gene therapy can have varying side effects, often related to the immune system response, such as inflammation or autoimmune reactions.

In conclusion, while traditional treatments for Paget Disease of the Nipple are well-established, ongoing research continues to improve outcomes and develop innovative therapies. Patients should consult with their healthcare team to understand the best options available for their specific condition.